Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Federal Trade Commission
Argus Health
Merck
AstraZeneca
Citi
Fish and Richardson
Cerilliant

Generated: June 21, 2018

DrugPatentWatch Database Preview

STELAZINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Stelazine patents expire, and when can generic versions of Stelazine launch?

Stelazine is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in STELAZINE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.
Summary for STELAZINE
Drug patent expirations by year for STELAZINE
Medical Subject Heading (MeSH) Categories for STELAZINE
Synonyms for STELAZINE
10-(.gamma.-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiozine
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-10H-phenothiazine
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazin
10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-phenothiazine
10-(3-(4-Methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)phenothiazine
10-(3-(4-methylpiperazin-1-yl)propyl)-2-(trifluoromethyl)-10H-phenothiazine
10-(gamma-(n inverted exclamation mark -methylpiperazino)propyl)-2-trifluoromethylphenothiazine
10-(gamma-(n inverted exclamation mark -methylpiperazino)propyl)-2-trifluoromethylphenothiozine
10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiazine
10-(gamma-(N'-Methylpiperazino)propyl)-2-trifluoromethylphenothiozine
10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-Methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-10H-phenothiazine #
10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)phenothiazine;hydrochloride
10-[3-(4-METHYL-PIPERAZIN-1-YL)-PROPYL]-2-TRIFLUOROMETHYL-10H-PHENOTHIAZINE
10-[3-(4-methylpiperazin-1-yl)-propyl]-2-trifluoromethylphenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)-10H-phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine
10-[3-(4-methylpiperazin-1-yl)propyl]-2-(trifluoromethyl)phenothiazine;hydrochloride
10-[3-(4-methylpiperazino)propyl]-2-(trifluoromethyl)phenothiazine;hydrochloride
10H-Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-
10H-Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-
117-89-5
2-Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
2-Trifluoromethyl-10-[3'-(1-methyl-4-piperazinyl)propyl]phenothiazine
214IZI85K3
3B1-000607
5858-EP2302003A1
5858-EP2309505A1
AB00053558
AB00053558_28
AB00053558_29
AB00053558-27
AC1L1KMT
AC1Q3ZYE
AJ-73370
AK122004
AKOS001487920
AN-22776
Apo-Trifluoperazine
Apo-trifluoperazine (TN)
AX8155275
BDBM79181
BIDD:PXR0132
Bio1_000458
Bio1_000947
Bio1_001436
Bio2_000435
Bio2_000915
Biomol-NT_000060
BPBio1_000338
BPBio1_001345
BRD-K89732114-001-02-6
BRD-K89732114-001-03-4
BRD-K89732114-300-05-5
BSPBio_000306
BSPBio_001190
BSPBio_002928
C07168
C21H24F3N3S
Calmazine
CAS-440-17-5
CCG-37306
CCRIS 6994
CHEBI:45951
CHEMBL422
cid_2913535
cid_5566
cMAP_000048
D08636
D0R4OM
DB00831
DivK1c_000843
DTXSID1046928
EINECS 204-219-4
Eskazine
Eskazine (TN)
Eskazinyl (TN)
Fluoperazine
Fluoperazine (Salt/Mix)
Flupazine
Flurazine
FT-0650159
GTPL214
HMS1362L11
HMS1792L11
HMS1990L11
HMS2089J11
HMS3429O07
HSDB 3195
IDI1_000843
IDI1_002190
Jatroneural (Salt/Mix)
Jatroneural (TN)
KB-217586
KBio1_000843
KBio2_000530
KBio2_001148
KBio2_002431
KBio2_003098
KBio2_003716
KBio2_004999
KBio2_005666
KBio2_006284
KBio2_007567
KBio3_000959
KBio3_000960
KBio3_002148
KBio3_002910
KBioGR_000530
KBioGR_000835
KBioGR_002431
KBioSS_000530
KBioSS_001148
KBioSS_002437
KSC-210-031
KUC109776N
L001075
Lopac-T-8516
Lopac0_001232
LS-105595
M989
MCULE-3726407978
MLS001146870
MLS002702821
MLS006011857
Modalina
Modalina (TN)
MolPort-001-727-956
MRF-0000088
NCGC00013226
NCGC00013226-02
NCGC00013226-03
NCGC00013226-04
NCGC00013226-05
NCGC00013226-06
NCGC00013226-07
NCGC00013226-08
NCGC00013226-09
NCGC00013226-10
NCGC00013226-11
NCGC00013226-12
NCGC00013226-13
NCGC00013226-15
NCGC00024251-03
NCGC00024251-04
NCGC00024251-05
NCGC00024251-06
NCGC00024251-07
NCI17474
NCI60_001427
NCI60_004087
NCIStruc1_001127
NCIStruc2_001093
NINDS_000843
Novo-Trifluzine
NSC 17474
NSC 46061
NSC-17474
NSC17474
PDSP1_001300
PDSP2_001284
Phenothiazine, 10-(3-(4-methyl-1-piperazinyl)propyl)-2-(trifluoromethyl)-
Phenothiazine, 10-[3-(4-methyl-1-piperazinyl)propyl]-2-(trifluoromethyl)-
PL008217
PL042776
PMS Trifluoperazine
Prestwick0_000313
Prestwick1_000313
Prestwick2_000313
Prestwick3_000313
QTL1_000085
RP 7623
SBI-0051199.P003
SC-95890
SCHEMBL24866
SKF 5019
SMR001566649
SPBio_000755
SPBio_002525
Spectrum_000668
Spectrum2_000828
Spectrum3_001374
Spectrum4_000368
Spectrum5_001553
SR-01000003020-6
Stelazine (*Dihydrochloride*)
Stelazine (Salt/Mix)
Stelazine (TN)
Stelazine Concentrate
Stellazine
STK182873
STOCK1S-51401
Synklor (Salt/Mix)
Terfluzine (Salt/Mix)
Terfluzine (TN)
TFP
Trifluoperaz (TN)
Trifluoperazin
Trifluoperazin HCl
Trifluoperazina
Trifluoperazina [INN-Spanish]
Trifluoperazina [Italian]
trifluoperazine
Trifluoperazine (INN)
Trifluoperazine [INN:BAN]
Trifluoperazine HCl
Trifluoperazine hydrochloride
Trifluoperazinum
Trifluoperazinum [INN-Latin]
Trifluoromethyl-10-(3'-(1-methyl-4-piperazinyl)propyl)phenothiazine
Trifluoromethylperazine
Trifluoroperazine
Trifluoroperazine dihydrochloride
Trifluperazine
Triflurin
Trifluroperizine
Triftazin
Triftazin (Salt/Mix)
Triftazine
Triftazine (Salt/Mix)
Triperazine
Tripfluoperazine Hydrochloride
Triphtazin
Triphtazine
Triphthasine
Triphthazine (Salt/Mix)
UNII-214IZI85K3
ZEWQUBUPAILYHI-UHFFFAOYSA-N
ZINC19418959

US Patents and Regulatory Information for STELAZINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline STELAZINE trifluoperazine hydrochloride CONCENTRATE;ORAL 011552-006 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline STELAZINE trifluoperazine hydrochloride TABLET;ORAL 011552-002 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline STELAZINE trifluoperazine hydrochloride INJECTABLE;INJECTION 011552-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Glaxosmithkline STELAZINE trifluoperazine hydrochloride TABLET;ORAL 011552-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Baxter
Boehringer Ingelheim
Healthtrust
Farmers Insurance
Accenture
UBS
US Army
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.